Medication info
Rosuvastatin Calcium 10 mg Tablets

Rosuvastatin Calcium 10 mg Tablets

Prescription medicationTablet
Ingredient · strength
Rosuvastatin Calcium›10.4mg / 1 tablet
Manufacturer / importer
SaeHan Pharmaceutical Co., Ltd.
Appearance
Pink round film-coated tablets
Packaging
30 tablets/box [(15 tablets/PTP x 2)]
Approval status
Active

MFDS item code 202003845 · Approved 2020.05.26 · Insurance code 651300930

Summary

Main use
Improvement of dyslipidemia; inhibition of atherosclerosis progression; reduction of cardiovascular risk
Who uses it
Adults · Children
Adult dosage
1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medication and continue it throughout the treatment period. This medication may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily. If a greater reduction in LDL cholesterol is needed, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 milligrams once daily, which is sufficient to control the condition in most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and the patient's response; the dose may be increased to a maximum of 20 milligrams once daily. 3. Elderly patients : No dose adjustment is necessary. 4. Patients with renal impairment : No dose adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Particular caution is required when administering 20 mg of this medication to patients with moderate renal impairment. 5. Patients with hepatic impairment : No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medication to patients with active liver disease. 6. Race : Because systemic exposure to this medication is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 7. Patients predisposed to myopathy : The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose is contraindicated in some of these patients.
Children's dosage
Pediatric patients with heterozygous familial hypercholesterolemia (ages 10 to 17 years): The usual dose range is 5 milligrams to 20 milligrams once daily. (There are no clinical data on doses higher than 20 milligrams in pediatric patients.) Children under 10 years of age: Safety and efficacy have not been established.

Ingredients

Manufacturer
SaeHan Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of dyslipidemia; inhibition of atherosclerosis progression; reduction of cardiovascular risk

  • Primary hypercholesterolemia
  • mixed dyslipidemia
  • homozygous familial hypercholesterolemia
  • hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • primary dysbetalipoproteinemia
  • stroke risk
  • myocardial infarction risk
View approved original text

This drug is used as an adjunctive therapy when dietary management and exercise do not adequately control lipid disorders such as primary hypercholesterolemia and mixed dyslipidemia. It is also helpful as an adjunct to dietary management or other treatments in patients with familial hypercholesterolemia, lowering total cholesterol and LDL-cholesterol levels to delay the progression of atherosclerosis. In particular, it is used as an adjunct to dietary management to reduce cholesterol levels in pediatric patients with heterozygous familial hypercholesterolemia. It also helps in primary dysbetalipoproteinemia and contributes to reducing the risk of cardiovascular diseases, including stroke, myocardial infarction, and the risk of vascular revascularization. Overall, it is used to improve cardiovascular health.

Dosage and Administration

Adult dosage

1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medication and continue it throughout the treatment period. This medication may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily. If a greater reduction in LDL cholesterol is needed, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 milligrams once daily, which is sufficient to control the condition in most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and the patient's response; the dose may be increased to a maximum of 20 milligrams once daily. 3. Elderly patients : No dose adjustment is necessary. 4. Patients with renal impairment : No dose adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Particular caution is required when administering 20 mg of this medication to patients with moderate renal impairment. 5. Patients with hepatic impairment : No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medication to patients with active liver disease. 6. Race : Because systemic exposure to this medication is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 7. Patients predisposed to myopathy : The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose is contraindicated in some of these patients.

Children's dosage

Pediatric patients with heterozygous familial hypercholesterolemia (ages 10 to 17 years): The usual dose range is 5 milligrams to 20 milligrams once daily. (There are no clinical data on doses higher than 20 milligrams in pediatric patients.) Children under 10 years of age: Safety and efficacy have not been established.

Precautions

This drug should not be used in certain patients. First, it must not be administered to patients who have allergies to its ingredients, severe liver dysfunction, muscle diseases, or severe kidney diseases. Pregnant or nursing women, or women of childbearing potential who are not using appropriate contraception should avoid using this drug. Additionally, patients at high risk for myopathy or rhabdomyolysis, such as those with poor kidney function, hypothyroidism, and those who have previously experienced muscle toxicity reactions, are prohibited from taking this medication in high doses. This drug contains lactose, thus, it should not be administered to patients with lactose intolerance or certain genetic metabolic disorders. When taking this drug, liver function and muscle status should be periodically monitored, especially in patients who consume large amounts of alcohol or have a history of liver disease. Symptoms such as muscle pain, muscle weakness, and cramps should be discussed with a doctor immediately, and the use of this drug may need to be discontinued if necessary. Furthermore, use of this medication should be discontinued in cases where serious muscle issues or deterioration of kidney function is suspected. Rarely, severe muscle weakness or ocular muscle weakness may occur, and if such symptoms appear, use should be stopped immediately. This drug may increase blood concentrations when taken with certain medications, which can heighten the risk of muscle damage, thus patients should consult their doctor or pharmacist if they are on other medications. Pregnant or nursing women should not use this medication, and women of childbearing age should ensure they use appropriate contraception. In the event of an overdose, there is no specific antidote, so treatment should be symptomatic, monitoring liver function and muscle enzyme levels. This drug is known not to significantly affect driving or machine operating abilities, however, caution is required as dizziness may occur. Lastly, while on this medication, severe skin reactions may arise, so should any symptoms such as skin rash, redness, or swelling occur, medical personnel should be notified immediately.

Side effects

Hypersensitivity reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, pruritus, rash, urticaria, myalgia, myopathy, rhabdomyolysis, asthenia, polyneuropathy, amnesia, peripheral neuropathy, myasthenia gravis, cough, dyspnea, diarrhea, oculomotor weakness, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms (DRESS), lichenoid drug eruption, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, increased ALT, chest pain, muscle cramps, gout, erectile dysfunction, numbness, dysesthesia, chest discomfort, anorexia, abdominal distension, syncope, generalized pain, fatigue

Not everyone experiences these, and they can vary from person to person.

Storage

This drug is sensitive to air and moisture; therefore, it should be stored in a tightly closed container. Additionally, it is important to store it at room temperature between 1 degree and 30 degrees Celsius, avoiding extremes of heat or cold.

Appearance and packaging

Appearance

Pink round film-coated tablets

Package unit

30 tablets/box [(15 tablets/PTP x 2)]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.